Non-alcoholic fatty liver disease is the leading chronic liver disease affecting many non-drinkers in India. Early detection ...

Chronic liver disease gets worse when the liver's immune system stays overactive, resulting in ongoing inflammation and ...

Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita ...

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. Right now, patients with obesity and cirrhosis ...

Mitochondrial respiratory complexes (Complexes I–V) and their assembly into respiratory supercomplexes (SCs) are fundamental to liver bioenergetics, redox homeostasis, and metabolic adaptability.

Each year, more than two million people die from advanced chronic liver disease (ACLD). Previous research has linked gut ...

People with twice as much of the forever chemicals PFOA - found in non-stick cookware - and fire fighting PFHpA in their ...

Reducing liver fat has become a central target in the development of therapies for metabolic dysfunction–associated ...

The FDA expanded the indication for semaglutide (Wegovy) to treating adults with noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), the agency announced. The glucagon-like peptide-1 ...

The study builds on recent USC research showing that, for adolescents undergoing bariatric surgery to manage obesity, a PFAS ...

Children born to mothers who consume a high-fat, high-sugar diet during pregnancy and breastfeeding face a higher risk of ...